Expression profiling in ovarian cancer reveals coordinated regulation of BRCA1/2 and homologous recombination genes

Detalhes bibliográficos
Autor(a) principal: Custódio, Noélia
Data de Publicação: 2022
Outros Autores: Savisaar, Rosina, Carvalho, Célia, Bak-Gordon, Pedro, Ribeiro, Maria I., Almeida-Tavares, Joana, Nunes, Paula B., Peixoto, Carolina, Pinto, Carla, Escudeiro, Carla, Teixeira, Manuel R., Carmo-Fonseca, Maria
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/55077
Resumo: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
id RCAP_ac9a63afa4002cdcb29331da20ec7575
oai_identifier_str oai:repositorio.ul.pt:10451/55077
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Expression profiling in ovarian cancer reveals coordinated regulation of BRCA1/2 and homologous recombination genesOvarian cancerBRCA1/2 mRNAHomologous recombinationnCounter assayddPCR© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Predictive biomarkers are crucial in clarifying the best strategy to use poly(ADP-ribose) polymerase inhibitors (PARPi) for the greatest benefit to ovarian cancer patients. PARPi are specifically lethal to cancer cells that cannot repair DNA damage by homologous recombination (HR), and HR deficiency is frequently associated with BRCA1/2 mutations. Genetic tests for BRCA1/2 mutations are currently used in the clinic, but results can be inconclusive due to the high prevalence of rare DNA sequence variants of unknown significance. Most tests also fail to detect epigenetic modifications and mutations located deep within introns that may alter the mRNA. The aim of this study was to investigate whether quantitation of BRCA1/2 mRNAs in ovarian cancer can provide information beyond the DNA tests. Using the nCounter assay from NanoString Technologies, we analyzed RNA isolated from 38 ovarian cancer specimens and 11 normal fallopian tube samples. We found that BRCA1/2 expression was highly variable among tumors. We further observed that tumors with lower levels of BRCA1/2 mRNA showed downregulated expression of 12 additional HR genes. Analysis of 299 ovarian cancer samples from The Cancer Genome Atlas (TCGA) confirmed the coordinated expression of BRCA1/2 and HR genes. To facilitate the routine analysis of BRCA1/2 mRNA in the clinical setting, we developed a targeted droplet digital PCR approach that can be used with FFPE samples. In conclusion, this study underscores the potential clinical benefit of measuring mRNA levels in tumors when BRCA1/2 DNA tests are negative or inconclusive.This research was funded by the Fundação para a Ciência e a Tecnologia, Portugal (PTDC/MED-ONC/29469/2017) and an unrestricted grant from AstraZeneca to M.C.-F. R.S. was a recipient of an EMBO Long-Term Fellowship (EMBO ALTF 101-2019). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 842695.MDPIRepositório da Universidade de LisboaCustódio, NoéliaSavisaar, RosinaCarvalho, CéliaBak-Gordon, PedroRibeiro, Maria I.Almeida-Tavares, JoanaNunes, Paula B.Peixoto, CarolinaPinto, CarlaEscudeiro, CarlaTeixeira, Manuel R.Carmo-Fonseca, Maria2022-11-11T16:35:38Z20222022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/55077engBiomedicines 2022, 10(2), 19910.3390/biomedicines100201992227-9059info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-11-20T18:17:39Zoai:repositorio.ul.pt:10451/55077Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-11-20T18:17:39Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Expression profiling in ovarian cancer reveals coordinated regulation of BRCA1/2 and homologous recombination genes
title Expression profiling in ovarian cancer reveals coordinated regulation of BRCA1/2 and homologous recombination genes
spellingShingle Expression profiling in ovarian cancer reveals coordinated regulation of BRCA1/2 and homologous recombination genes
Custódio, Noélia
Ovarian cancer
BRCA1/2 mRNA
Homologous recombination
nCounter assay
ddPCR
title_short Expression profiling in ovarian cancer reveals coordinated regulation of BRCA1/2 and homologous recombination genes
title_full Expression profiling in ovarian cancer reveals coordinated regulation of BRCA1/2 and homologous recombination genes
title_fullStr Expression profiling in ovarian cancer reveals coordinated regulation of BRCA1/2 and homologous recombination genes
title_full_unstemmed Expression profiling in ovarian cancer reveals coordinated regulation of BRCA1/2 and homologous recombination genes
title_sort Expression profiling in ovarian cancer reveals coordinated regulation of BRCA1/2 and homologous recombination genes
author Custódio, Noélia
author_facet Custódio, Noélia
Savisaar, Rosina
Carvalho, Célia
Bak-Gordon, Pedro
Ribeiro, Maria I.
Almeida-Tavares, Joana
Nunes, Paula B.
Peixoto, Carolina
Pinto, Carla
Escudeiro, Carla
Teixeira, Manuel R.
Carmo-Fonseca, Maria
author_role author
author2 Savisaar, Rosina
Carvalho, Célia
Bak-Gordon, Pedro
Ribeiro, Maria I.
Almeida-Tavares, Joana
Nunes, Paula B.
Peixoto, Carolina
Pinto, Carla
Escudeiro, Carla
Teixeira, Manuel R.
Carmo-Fonseca, Maria
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Custódio, Noélia
Savisaar, Rosina
Carvalho, Célia
Bak-Gordon, Pedro
Ribeiro, Maria I.
Almeida-Tavares, Joana
Nunes, Paula B.
Peixoto, Carolina
Pinto, Carla
Escudeiro, Carla
Teixeira, Manuel R.
Carmo-Fonseca, Maria
dc.subject.por.fl_str_mv Ovarian cancer
BRCA1/2 mRNA
Homologous recombination
nCounter assay
ddPCR
topic Ovarian cancer
BRCA1/2 mRNA
Homologous recombination
nCounter assay
ddPCR
description © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
publishDate 2022
dc.date.none.fl_str_mv 2022-11-11T16:35:38Z
2022
2022-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/55077
url http://hdl.handle.net/10451/55077
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Biomedicines 2022, 10(2), 199
10.3390/biomedicines10020199
2227-9059
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817549208954077184